Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1992-06-24
1993-11-23
Moskowitz Parr, Margaret
Chemistry: molecular biology and microbiology
Spore forming or isolating process
4352401, C12N 500, C12N 506
Patent
active
052643581
ABSTRACT:
The present invention relates to a novel cell line isolated from a rat osteosarcoma wherein the cell line has the following characteristics: a) a mutated p53 gene incapable of expressing p53 protein, b) a normal RB-1 gene, c) a 10-fold amplified c-myc gene, d) a normal c-fos gene, e) a deregulated immediate early gene response, f) a canalicular network MATRIGEL.TM. growth pattern, g) tumorigenic in congenitally athymic mice, h) no alkaline phosphatase activity, i) an ability to produce one or more growth factors selected from the group consisting of: 1) an osteoblastic differentiation growth factor, 2) a non-heparin binding mitogenic growth factor, 3) a first heparin binding mitogenic growth factor, 4) a second heparin binding mitogenic growth factor, and 5) a third heparin binding mitogenic growth factor, and j) an ability to be serially propagated greater than sixty population doublings. The present invention also relates to growth factors having the characteristics of growth factors isolated from the rat osteosarcoma cell line. The present invention also relates to a process for producing a growth factor which comprises: a) growing an osteosarcoma cell line in a culture medium, and b) recovering the growth factor from the medium. The present invention also relates to a process for producing a growth factor comprising: a) isolating mRNA from an osteosarcoma cell line which codes for the growth factor, b) making cDNA of the mRNA, c) expressing the cDNA in an expression vector, and d) recovering the growth factor.
REFERENCES:
patent: 5035901 (1991-07-01), Anderson et al.
Wrana et al., Biochem. J., (1991), 273:523-531.
Rodan et al., Crit. Rev. Eukaryot. Gene Expr., (1991), 1:85-98.
"Bone-Inducing Agent (BIA) from Cultured Human Saos-2 Osteosarcoma Cells", Anderson, H. C., K. Sugamoto, D. C. Morris, H. H. T. Hsu, & T. Hunt, Bone and Mineral, 16, (1992), pp. 49-62.
"Oncogene, Tumor Suppressor Gene, and Growth Signal Transduction Alterations in a Series of Chemically-Induced Rat Osteosarcomas", Isfort, R. J., D. C. Cody, G. Lovell & C. J. Doersen, Poster Presentation, Seventh Annual Oncogene Meeting, Frederick, Md., Jun. 24, 1991.
"Growth Factors in Development, Transformation, and Tumorigenesis", Cross, M. and T. M. Dexter, Cell, vol. 64, pp. 271-280, (1991).
"Insulin Promotes Growth of the Cultured Rat Osteosarcoma Cell Line UMR-106-01: An Osteoblast-Like Cell", Hickman, J. and A. McElduff, Endocrinology, vol. 124, No. 2, pp. 701-706, (1989).
"Negative Regulators of Cell Growth", Wang, J. L. and Y. M. Hsu, TIBS 11 (1986).
"Growth Factors: Mechanism of Action and Relation to Oncogenes", Heldin, C. H. and Westermark, B., Cell, vol. 37, pp. 9-20, (1984).
"Production of An Insulin-like Growth Factor by Osteosarcoma", Blatt, J., C. White, S. Dienes, H. Friedman and T. P. Foley, Jr., Biochemical and Biophysical Research Communications, vol. 123, No. 1, pp. 373-376, (1984).
Doersen Claus-Jens W.
Isfort Robert J.
Corstanje Braham J.
Graff IV Milton B.
Moskowitz Parr Margaret
Myers Carla
The Procter & Gamble & Company
LandOfFree
Rat osteosarcoma cell line OSR9TR1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rat osteosarcoma cell line OSR9TR1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rat osteosarcoma cell line OSR9TR1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1848335